DIN 02423596 — INCRUSE ELLIPTA 62.5 MCG
INCRUSE ELLIPTA is a powder of Umeclidinium marketed by GLAXOSMITHKLINE INC. The full Umeclidinium monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02423596
- Brand name
- INCRUSE ELLIPTA
- Active ingredient
- Umeclidinium
- Strength
- 62.5 MCG
- Dosage form
- POWDER
- Route
- INHALATION
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- Long-acting muscarinic antagonist (LAMA) bronchodilator
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.